Home About USTH Find A USTH Doctor Contact Us      
Home - Services
 
 
   Home
   About USTH
  Patient and Visitor
   Information
   For International
   Patients
   Corporate Governance
  Training
   Services
 :: General Services ::
    Special Services
   > Acute Stroke Unit
   > Catheterization
        Laboratory
   > Center for Kidney
        Disease
   > Center for
        Respiratory Medicine
   > Center for
        Urological Services
   > Chemotherapeutic
        Unit
   > Dermatology
        Center
   > Endoscopy Unit
   > Eye Center
   > Hearing and
       Dizziness Center
   > Heart Station and
       Echo Laboratory
   > High Risk Unit
   > Joint and Bone
       Center
   > Neuromuscular Unit
   > Orthopedic Care
       Center
   > Pain Management
       Unit
   > Short Stay Oncology
   > St. Thomas
       Diabetic Center
 :: Pastoral Services ::
   Departments
   Benavides Cancer
   Institute
   Research Unit
  Career Opportunity
  Find A USTH Doctor
   Contact Us
 
 
  What's New
NEW EQUIPMENT PROFILE The UST Hospital continues its aggressive equipment-updating program with these new acquisitions.
Our Services
       
  Announcement
Postgraduate Opening for the Year 2012
 
  People
Profiles of people who form part of our institution. Get to know your doctors, nurses, hospital administration and staff and other co-workers.
 
  CEO's Corner
USTH CEO Fr. dela Rosa Restates USTH Objectives
 

Catheterization
Laboratory

About Catheterization Laboratory
Services and Facilities
What's New
Contact Us

 


Treatment of cardiovascular diseases has gone a long way. Minimally invasive treatment is becoming the trend which improves every year. The era of opening coronary artery blockages with the use of plain balloons was replaced with bare metal stents deployment and now with drug eluting stents.

Stents are metal scaffoldings that are being placed inside the blocked artery to keep it open. Technology improved the stent system by coating it with a drug mainly sirolimus (Cypher stent) or paclitaxel (Taxus stent). These drug coated stents or drug eluting stents (DES) brought down the incidence of restenosis (return of the blockage) rate to less than eight percent in comparison to the previous technology of as high as 50 percent.

The UST Cardiac Catheterization lab offers angioplasty using the drug eluting stent technology.